Kintiga BeNeLux
Navigate the complex pathway to patients with ease
Kintiga BeNeLux
We are a team of bold, dynamic thinkers with deep expertise in pharmaceutical market access, regulatory affairs, medical and scientific strategy, and public policy. Rooted in local expertise and driven by global collaboration, we empower health technology developers to deliver impactful therapies to patients across Europe.
Our approach combines agility with precision, guiding you through the complexities of European patient access with confidence and clarity.
BeNeLux Insights
Kintiga BeNeLux
Our expertise:
BeNeLux Access Consultancy
Our BeNeLux team delivers bespoke, region-specific strategies that support your product’s journey from early development through long-term market presence.
BeNeLux Market Access Pathways
The key to success begins with a clear, well-defined pathway to product launch. With Kintiga, you gain a partner who understands the nuance behind every national opportunity with local expertise in Benelux.
BeNeLux HTA Strategy Support
Our BeNeLux consultants are experts on the rigorous requirements of a Joint Clinical Assessment. From early scientific advice of the JSC to the JCA Report, we offer integrated solutions to ensure your product’s success in the EU Health Technology Assessment process.
Regulatory Compliance
Navigating the regulatory landscape is not just about ensuring compliance, it’s about steering innovation safely through the seas of change.
BeNeLux HEOR
Market access is like a game of chess. You need a clear strategy, anticipate, and make the right moves at the right time. But unlike chess, the game of market access is about making a difference in people’s lives.
Medical Affairs
Medical affairs is the bridge between science and humanity where innovation meets impact.
BeNeLux Insights
Bringing Clarity to Article 10: What the New Belgian FAMHP Guidance Means for Pharma
World EPA Congress 2026
Highlights from the Healixia-EUFEMED Conference 2025
Reflections on the 2025 World Evidence, Pricing and Access Conference in Amsterdam
Kintiga™ to be officially launched at the World EPA Congress in Amsterdam, 5-6 March 2025
Our products
Navigate evolving regulations and market demands confidently with up-to-date insights and guidance from Kintiga’s innovative AI-powered digital tools.
Hive by Kintiga
Access the collective expertise of our consultants and the insights and strategic guidance to simplify approvals across Europe’s healthcare any time and from anywhere.
EPRI
EPRI (EndPoint Result Interpreter) is a cutting-edge AI solution designed to streamline the creation of tailored, high-quality dossiers.
Get in touch with our team now
Contact us to discover how we can support your journey towards pharmaceutical market access & patient access.
